GT
LLY icon

Greenleaf Trust’s Eli Lilly LLY Stock Holding History

Greenleaf Trust’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.3M Buy
21,113
+591
+3% +$604K 0.24% 36
2026
Q1 		$18.9M Sell
20,522
-193
-0.9% -$196K 0.19% 40
2025
Q4 		$22.3M Buy
20,715
+466
+2% +$446K 0.2% 37
2025
Q3 		$15.4M Sell
20,249
-3,841
-16% -$2.86M 0.14% 49
2025
Q2 		$18.8M Sell
24,090
-2,047
-8% -$1.59M 0.17% 38
2025
Q1 		$21.6M Buy
26,137
+70
+0.3% +$58.2K 0.2% 34
2024
Q4 		$20.1M Sell
26,067
-2,370
-8% -$1.96M 0.18% 37
2024
Q3 		$25.2M Buy
28,437
+505
+2% +$454K 0.22% 31
2024
Q2 		$25.3M Buy
27,932
+1,868
+7% +$1.49M 0.24% 29
2024
Q1 		$20.3M Sell
26,064
-2,970
-10% -$2.11M 0.19% 38
2023
Q4 		$16.9M Buy
29,034
+5,210
+22% +$3.04M 0.18% 41
2023
Q3 		$12.8M Buy
23,824
+86
+0.4% +$44.3K 0.15% 44
2023
Q2 		$11.1M Sell
23,738
-1,143
-5% -$479K 0.12% 54
2023
Q1 		$8.54M Buy
24,881
+82
+0.3% +$27.7K 0.1% 63
2022
Q4 		$9.07M Sell
24,799
-43,274
-64% -$15.3M 0.11% 60
2022
Q3 		$22M Buy
68,073
+45,191
+197% +$14.3M 0.33% 21
2022
Q2 		$7.42M Buy
22,882
+1,326
+6% +$398K 0.11% 53
2022
Q1 		$6.17M Buy
21,556
+966
+5% +$249K 0.07% 59
2021
Q4 		$5.69M Buy
20,590
+1,332
+7% +$338K 0.07% 70
2021
Q3 		$4.45M Buy
19,258
+231
+1% +$57K 0.05% 73
2021
Q2 		$4.37M Buy
19,027
+257
+1% +$51.6K 0.05% 75
2021
Q1 		$3.51M Buy
18,770
+1,925
+11% +$377K 0.05% 81
2020
Q4 		$2.84M Buy
16,845
+1,433
+9% +$214K 0.04% 91
2020
Q3 		$2.28M Sell
15,412
-928
-6% -$144K 0.04% 92
2020
Q2 		$2.68M Buy
16,340
+2,399
+17% +$368K 0.05% 84
2020
Q1 		$1.93M Buy
13,941
+1,883
+16% +$259K 0.04% 92
2019
Q4 		$1.58M Buy
12,058
+343
+3% +$39.8K 0.02% 121
2019
Q3 		$1.31M Sell
11,715
-20
-0.2% -$2.23K 0.02% 132
2019
Q2 		$1.3M Sell
11,735
-215
-2% -$25.3K 0.02% 139
2019
Q1 		$1.55M Buy
11,950
+548
+5% +$66.6K 0.03% 115
2018
Q4 		$1.32M Buy
11,402
+483
+4% +$54K 0.03% 122
2018
Q3 		$1.17M Buy
10,919
+1,104
+11% +$110K 0.02% 147
2018
Q2 		$838K Buy
9,815
+2,686
+38% +$221K 0.02% 184
2018
Q1 		$552K Sell
7,129
-119
-2% -$9.58K 0.01% 228
2017
Q4 		$612K Buy
7,248
+1,102
+18% +$93.8K 0.01% 211
2017
Q3 		$526K Buy
6,146
+1,559
+34% +$128K 0.01% 221
2017
Q2 		$378K Buy
4,587
+589
+15% +$48.1K 0.01% 239
2017
Q1 		$336K Buy
3,998
+645
+19% +$51.7K 0.01% 205
2016
Q4 		$247K Buy
+3,353
New +$250K 0.01% 203

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Greenleaf Trust's LLY Position: Q2 2026 in Review

Greenleaf Trust increased its Eli Lilly (LLY) stake by 2.9% in Q2 2026, buying an estimated $604K and bringing the position to 21,113 shares worth $25.3M. The position accounts for 0.24% of the portfolio, ranked #36.

Greenleaf Trust first reported a position in LLY in Q4 2016 and has held it in 39 quarters since. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Greenleaf Trust held 21,113 shares of Eli Lilly worth $25.3M as of Q2 2026.
  • Greenleaf Trust bought 591 Eli Lilly shares in Q2 2026, an estimated $604K.
  • Eli Lilly made up 0.24% of Greenleaf Trust's portfolio in Q2 2026, its #36 holding.
  • Greenleaf Trust first reported a position in Eli Lilly in Q4 2016 and has held it in 39 quarters since.
  • 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.